PARMAR KUSH Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$28M
Insider Sells Quantity
5
Insider Sells Sum
$10.3M

Insider Activity of PARMAR KUSH

According to the SEC Form 4 filings, PARMAR KUSH, being in a position of

  1. director at Entrada Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 471729 shares for $3.65M,
    over all time since 2021-11-02, has bought 500000 shares for $10M, and sold 623729 shares for $4.72M.

Biography of PARMAR KUSH

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,645,9656100

Comparison of Insiders on Amount of Buys and Sells

2026-08-10SaleEntrada Therapeutics, Inc.
TRDA
director
92,444
0.2205%
$7.00$647,108-7.05%
2026-08-07SaleEntrada Therapeutics, Inc.
TRDA
director
52,317
0.1235%
$6.85$358,371-5.39%
2026-08-06SaleEntrada Therapeutics, Inc.
TRDA
director
10,494
0.0253%
$7.00$73,458-4.37%
2026-07-31SaleEntrada Therapeutics, Inc.
TRDA
1,718
0.0041%
$6.85$11,768-0.88%
2026-07-30SaleEntrada Therapeutics, Inc.
TRDA
114,756
0.2808%
$6.93$795,259-0.3%
2025-11-14SaleEntrada Therapeutics, Inc.
TRDA
200,000
0.5245%
$8.80$1.76M-12.11%
2025-07-09SaleEntrada Therapeutics, Inc.
TRDA
27,000
0.0705%
$7.50$202,554-0.4%
2025-07-01SaleEntrada Therapeutics, Inc.
TRDA
25,000
0.066%
$7.12$178,065+6.05%
2025-06-30SaleEntrada Therapeutics, Inc.
TRDA
25,000
0.0668%
$6.81$170,318+9.52%
2025-06-27SaleEntrada Therapeutics, Inc.
TRDA
75,000
0.1976%
$6.91$518,250+6.15%
2023-03-07SaleRallybio Corporation
RLYB
director
100,000
0.242%
$8.20$820,000-44.36%
2022-06-03SaleRallybio Corporation
RLYB
99,671
0.4398%
$12.50$1.25M-23.7%
2022-05-23SaleRallybio Corporation
RLYB
33,553
0.1126%
$13.00$436,189-43.36%
2022-02-08SaleRallybio Corporation
RLYB
director
210,000
0.6366%
$13.05$2.74M-36.62%
2021-11-16SaleVor Biopharma Inc.
VOR
330,706
0.7914%
$15.30$5.06M-69.06%
2021-11-02PurchaseEntrada Therapeutics, Inc.
TRDA
500,000
6.2616%
$20.00$10M-53.61%
2021-08-02PurchaseRallybio Corporation
RLYB
director
615,384
1.6145%
$13.00$8M-39.61%
2021-02-09PurchaseVor Biopharma Inc.
VOR
555,555
1.045%
$18.00$10M-63.24%
Total: 18
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.